Skip to Main Content
It looks like you're using Internet Explorer 11 or older. This website works best with modern browsers such as the latest versions of Chrome, Firefox, Safari, and Edge. If you continue with this browser, you may see unexpected results.

COVID-19 Intelligence Report: Resources: Decision-Support Tools, Calculators, Treatment Algorithms

June 1, 2020

Title: Clinical management of COVID-19 Publisher: WHO

Publication Date: May 27, 2020


Key Takeaway: WHO released their updated (62 page very detailed) Clinical Management guidelines intended for clinicians caring for COVID-19 patients during all phases of their disease (i.e. screening to discharge) and includes:

  • Updated COVID-19 care pathway, treatment of acute and chronic infections, management of neurological and mental manifestations, noncommunicable diseases, rehabilitation, palliative care and ethical principles..
  • One of the key changes in the guidance is the recommendation to discontinue transmission-based precautions (including isolation) and release from the COVID-19 care pathway for symptomatic patients 10 days after symptom onset, plus an additional three days without symptoms (without fever and respiratory symptoms).
  • Recommended prevention of complications include:
    • Prevention of venous thromboembolismIn patients (adults and adolescents) when hospitalized
    • WHO recommends that the listed drugs including antivirals, immunomodulators and other adjunctive therapies should not be administered as treatment or prophylaxis for COVID-19 outside the context of clinical trials.
    • WHO recommends against the routine use of systemic corticosteroids for treatment of viral pneumonia.


Title: Sickle Cell Disease (SCD) Patients Presenting to the Emergency Department During the COVID-19 Pandemic: Considerations and a Checklist [librarian]

Publisher: American Society of Hematology

Publication Date: May 18, 2020


Key Takeaway: This is an ASH expert panel-derived checklist to assist in the evaluation of SCD patients in the ED presenting with symptoms concerning for COVID-19 and/or complications of SCD, with SCD-specific considerations for evaluation and treatment.

Preliminary data suggests that SCD patients may have higher mortality from COVID-19 due to underlying predisposing conditions related to SCD (cardiac diastolic dysfunction, asthma, pulmonary hypertension, cerebrovascular disease, renal dysfunction, thrombotic risk) and/or severe SCD complications such as acute chest syndrome or PE secondary to COVID- 19 infection.

Title: Medicine Basecamp

Publisher: McMaster University and University of Toronto Publication Date: March 30, 2020

URL: and

Key Takeaway: This is an education resource designed for trainees (but would be useful for any clinicians) who are refreshing their internal medicine content knowledge for redeployment for Covid-19 clinical care. Designed as a 10 week on-line curriculum, each subspecialty week consists of five medicine topic podcasts outlining physiology, history, physical, investigations, and management. A visual aid consolidates material and assists with information recall. Practical management strategies are also provided.

May 18, 2020

Title: NIOSH PPE Tracker App

Publisher: National Institute of Occupational Safety and Health (NIOSH)

Publication Date: May 4, 2020


Key Takeaway:  The NIOSH PPE Tracker App can help healthcare and non-healthcare systems track their personal protective equipment (PPE) inventory. Facilities can use the app to calculate their average PPE consumption rate or “burn rate.” The app estimates how many days a PPE supply will last given current inventory levels and PPE burn rate. It allows entry by # of individual units or boxes of supply, can calculate for a wide variety of specific PPE (such as small N95s), and varying number of patients. App will also create downloadable reports that can be shared via email. Available on iOS and Android.


Note: Although many organizations have released PPE burn rate trackers, this application may have additional functionality that health administrators may find useful, as outlined above.


The Himmelfarb Health Sciences Library
Questions? Ask us.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

The George Washington University